Stellar Financial Projections
Wearable tech innovator Ultrahuman is poised for a remarkable leap, projecting revenues to soar to Rs 1,100 crore in FY26, nearly doubling its FY25 revenue of Rs 565 crore. In an exclusive conversation with Entrackr, founder Mohit Kumar revealed that the company’s annualised run rate (ARR) underpins this ambitious forecast. Despite a projected profit increase of 1.5X, Kumar emphasized a strategic pivot toward long-term innovation over short-term gains. “We’re channeling investments into R&D and new facilities to build sustainable capabilities,” he said.
Table of Contents
Global Expansion Fuels Growth
Ultrahuman’s international footprint is expanding rapidly, with Europe, the UK, and Canada now matching the US in market traction. “Over the past six months, these regions have shown robust adoption,” Kumar noted. To solidify its European presence, the company recently acquired a UK-based firm, boosting its competitive edge. With a 25% year-on-year growth in global markets, Ultrahuman is already a top player in Europe’s wearable tech category after just over two years.
Scaling Europe, however, presents unique challenges. “It’s a fragmented market requiring localized strategies, from language to distribution,” Kumar explained. In contrast, the US offers a centralized retail ecosystem through giants like Amazon, Costco, and Walmart, but demands navigating fierce competition, litigation, and stringent pricing dynamics.
Driving User Growth with Innovative Products
With a user base exceeding 500,000 and monthly additions of 70,000–120,000 during peak seasons, Ultrahuman’s Ring and Blood Vision products are leading the charge. “The Ring is our flagship, especially popular among women for its aesthetic appeal and features like temperature tracking for ovulation and fertility,” Kumar shared, noting that 60–65% of Ring users are female. The Continuous Glucose Monitoring (CGM) service, boasting a 95% retention rate, remains a steady revenue driver.
Margins and Market Strategy
Ultrahuman’s gross margins reflect its diverse portfolio: 55% for Rings, 32% for M1, and 29% for Ultrahuman Home. Subscriptions, contributing 16% to revenue, show strong renewal rates of 75–80%. While India accounts for only 6% of revenue, its share has doubled in the past year. To capitalize on this, Ultrahuman plans to roll out omnichannel retail in India, starting with Bengaluru in November, followed by Mumbai and Delhi.
Eyeing a $10 Billion Global Opportunity
The global health measurement device market, valued at $10 billion, is Ultrahuman’s next frontier. “The category moves 200,000–300,000 devices monthly. We aim to scale 5X in two years, targeting 1.5–2 million units and a 10% market share,” Kumar said. New markets like Thailand, Singapore, the Middle East, and Australia—regions with a strong health and fitness focus—are also on the radar.
Advice for Indian Startups Going Global
Kumar offered candid insights for Indian startups eyeing international markets. “In the US, success hinges on mastering litigation, automation, distribution, and hiring. Competitors leverage patents, regulations, and lobbying to gain an edge,” he cautioned. He also highlighted untapped opportunities for Indian brands, particularly in organic food and lifestyle products. “The West is increasingly drawn to raw, additive-free products, creating space for Indian innovators,” he said, citing companies like Atomberg as examples of potential global disruptors.
aslo read : Ignosis Secures $4M in Pre-Series A to Revolutionize Financial Data Intelligence
Last Updated on Thursday, October 9, 2025 8:00 am by Startup Newswire Team
